Aeterna Zentaris to Present at Cowen and Company 32nd Annual Health Care Conference in Boston

QUÉBEC CITY, Feb. 29, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Senior Vice President and Chief Medical Officer,

Paul Blake, MD, will be presenting a corporate overview at the Cowen and Company 32^nd Annual Health Care Conference on Wednesday, March 7, 2012, at 8:40 am (Eastern), at the Boston Marriott Copley Place in Boston, MA.

A live audio webcast of this presentation will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcasts will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit www.aezsinc.com.

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
[phone] ext. 265
[email protected]

Media Relations
Paul Burroughs
Director of Communications
[phone] ext. 406
[email protected]